Author

A. E. Davis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Organism:zebrafish· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:development & morphogenesis· 2 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2

Frequent Co-Authors

A. N. Stratman· 3 shared B. M. Weinstein· 3 shared D. Castranova· 3 shared V. N. Pham· 3 shared M. C. Burns· 2 shared O. M. Farrelly· 2 shared A. Jain· 1 shared A. Newcombe· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

A. N. Stratman

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Regulation of angiogenesis by endocytic trafficking mediated by cytoplasmic dynein 1 light intermediate chain 1

D. Johnson, S. Colijn, J. Richee, J. Yano, M. Burns, A. E. Davis, V. N. Pham, A. Saric, A. Jain, Y. Yin, D. Castranova, M. Melani, M. Fujita, S. Grainger, J. S. Bonifacino, , A. N. Stratman

This study shows that LIC1 and RILPL1/2 restrict angiogenesis by promoting VEGFR2 degradation, and their disruption increases angiogenesis through enhanced Rab11-mediated recycling.

bioRxiv · Apr 1, 2024Cell Biology

BRD4-mediated repression of p53 is a target for combination therapy in AML

A.-L. Latif, A. Newcombe, S. Li, K. Gilroy, N. Robertson, X. Lei, H. Stewart, J. Cole, M. T. Terradas, L. Rishi, L. McGarry, C. McKeeve, C. Reid, W. Clark, J. Campos, , P. D. Adams

This study shows that combining MDM2 inhibitors and BET inhibitors synergistically kills AML cells by enhancing p53 activation through BRD4's repressive function.

bioRxiv · Sep 16, 2020Cell Biology

A Molecular Pathway for Arterial-Specific Association of Vascular Smooth Muscle Cells

A. N. Stratman, M. C. Burns, O. M. Farrelly, A. E. Davis, W. Li, V. N. Pham, D. Castranova, J. J. Yano, L. M. Goddard, O. Nguyen, M. Venero Galanternik, T. J. Bolan, M. L. Kahn, Y. Mukouyama, B. M. Weinstein

The paper identifies a molecular pathway involving cxcr4a/cxcl12b and pdgfb that drives arterial-specific accumulation of vascular smooth muscle cells during zebrafish development.

bioRxiv · Dec 27, 2019 · PreprintCell Biology

Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling

A. N. Stratman, O. M. Farrelly, C. M. Mikelis, M. F. Miller, Z. Wang, V. N. Pham, A. E. Davis, M. C. Burns, S. A. Pezoa, D. Castranova, T. M. Kilts, G. E. Davis, J. S. Gutkind, B. M. Weinstein

The paper shows that inhibiting phosphoinositide recycling in endothelial cells reduces tumor growth and angiogenesis by impairing VEGF signaling.

bioRxiv · Apr 18, 2019Cell Biology